Junya Hironaka

Junya Hironaka

Auto-generated profile, based on publicly available information

Junya Hironaka

Department of Endocrinology and Metabolism, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2024 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
TITakahiro Ichikawa
Takahiro Ichikawa
Hiroshi OkadaHiroshi Okada
Hiroshi Okada
JHJunya Hironaka
Junya Hironaka
HNHanako Nakajima
Hanako Nakajima
TOTakuro Okamura
Takuro Okamura
MFMichiaki Fukui
Michiaki Fukui
Aims/Introduction: Efficacy of long‐term low‐carbohydrate diets (LCD) to improve glycemic management for type 2 diabetes remains controversial. Thus, we investigated the association between long‐term LCD and glycemic control in individuals with type 2 diabetes.Materials and Methods: We searched PubMed, Embase and the Cochrane Database for articles published up to June 2023, and included randomized controlled trials conducted on LCD interventions for >12 months in adults with type 2 diabetes. Primary outcome was the difference in glycated hemoglobin between long‐term LCD and control groups. Additionally, we evaluated the differences in changes in systolic and diastolic blood pressure, low‐density lipoprotein cholesterol, high‐density lipoprotein cholesterol, triglyceride, and weight between long‐term LCD and control groups.Results: Six studies were identified and met the inclusion criteria. This study did not show significant differences in changes in glycated hemoglobin between long‐term LCD and control diets (standardized mean difference −0.11, 95% confidence interval −0.33 to 0.11, P = 0.32). As with glycemic control, there were no significant differences in the changes in weight loss, blood pressure, and low‐density lipoprotein cholesterol between long‐term LCD and control diets. However, long‐term LCD were associated with greater elevation in high‐density lipoprotein cholesterol (standardized mean difference 0.22, 95% confidence interval 0.04–0.41; P = 0.02) and decrease in triglyceride (standardized mean difference −0.19; 95% confidence interval −0.37 to 0.02; P = 0.03) than that in control diets.Conclusions: Our findings suggest efficacy of long‐term LCD in treating dyslipidemia in individuals with type 2 diabetes, but do not recommend long‐term LCD for glycemic control in the individuals.

17 June 2023 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
JHJunya Hironaka
Junya Hironaka
Hiroshi OkadaHiroshi Okada
Hiroshi Okada
MHMasahide Hamaguchi
Masahide Hamaguchi
KSKimiko Sakai
Kimiko Sakai
MMMegumi Minamida
Megumi Minamida
MFMichiaki Fukui
Michiaki Fukui

11 February 2024 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
SHShinnosuke Hata
Shinnosuke Hata
Hiroshi OkadaHiroshi Okada
Hiroshi Okada
MMMegumi Minamida
Megumi Minamida
JHJunya Hironaka
Junya Hironaka
YHYuka Hasegawa
Yuka Hasegawa
MFMichiaki Fukui
Michiaki Fukui

3 October 2024 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
JHJunya Hironaka
Junya Hironaka
Masahide HamaguchiMasahide Hamaguchi
Masahide Hamaguchi
TITakahiro Ichikawa
Takahiro Ichikawa
HNHanako Nakajima
Hanako Nakajima
TOTakuro Okamura
Takuro Okamura
MFMichiaki Fukui
Michiaki Fukui
Aims: Despite the reported success of low‐carbohydrate diets in improving glycemic control in the Western countries, no studies have investigated the effects of such diets in Asians. We aimed to conduct a systematic review and meta‐analysis of randomized controlled trials to examine the effects of low‐carbohydrate diets on glycemic control in East Asian adults.Materials and Methods: We systematically searched the PubMed, Cochrane Library, and Embase databases from inception to June 28, 2023, to identify randomized controlled trials examining the efficacy of low‐carbohydrate diets in patients with type 2 diabetes (PROSPERO number CRD 42023453007). The primary outcome was the difference in glycated hemoglobin levels between the low‐carbohydrate diet and control groups. The secondary outcome was the difference in body mass index, fasting blood glucose level, blood pressure, and lipid profile.Results: Six randomized controlled trials met the eligibility criteria. The study duration ranged from 3 to 18 months, with five studies conducted within 6 months. The results showed that low‐carbohydrate diets were more beneficial in lowering glycated hemoglobin levels and body mass index than control diets. The risk of bias for the six studies was minimal for two and moderate for four. The heterogeneity among the studies was low.Conclusions: Low‐carbohydrate diets improved glycated hemoglobin levels and body mass index in East Asians compared with control diets. Therefore, carbohydrate restriction may be effective for glycemic management in East Asians with type 2 diabetes for at least 6 months.

29 January 2025 in Diabetes & Vascular Disease Research
Verified
Journal Article
Open access
JHJunya Hironaka
Junya Hironaka
EUEmi Ushigome
Emi Ushigome
YKYuriko Kondo
Yuriko Kondo
YHYoshitaka Hashimoto
Yoshitaka Hashimoto
TOTakafumi Osaka
Takafumi Osaka
MFMichiaki Fukui
Michiaki Fukui
Background: This study aimed to investigate the effects of oral semaglutide on the changes in food preference of Japanese patients with type 2 diabetes. Methods: This retrospective multicenter study included 75 patients with type 2 diabetes who received oral semaglutide. The primary outcome was the change in the score of brief-type self-administered diet history questionnaire (BDHQ) score 3 months after the initiation of oral semaglutide treatment. The secondary outcome was the change in the Control of Eating Questionnaire (CoEQ), HbA1c, and body mass index (BMI) after 3 months. Results: The median age, BMI, and HbA1c of the 23 participants were 64.0 years, 26.9 kg/m2, and 7.6% (59 mmol/mol). The BDHQ results showed total energy was significantly reduced. Among the individual nutrients, carbohydrates most decreased. The CoEQ results particularly showed declines in cravings for something sweet, chocolate or chocolate flavored foods, and starchy foods, satisfaction at meals, frequency and intensity of food craving, difficulty of resisting the craving for food, and frequency of eating in response to cravings for food were significantly lower after 3 months. The mean HbA1c and BMI significantly decreased. Conclusions: In Japanese patients with type 2 diabetes, oral semaglutide treatment decreased total energy intake and changed food preferences.

14 February 2024 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
JHJunya Hironaka
Junya Hironaka
Hiroshi OkadaHiroshi Okada
Hiroshi Okada
MMMegumi Minamida
Megumi Minamida
YKYuriko Kondo
Yuriko Kondo
HNHanako Nakajima
Hanako Nakajima
MFMichiaki Fukui
Michiaki Fukui